BlackRock Health Sciences Term Trust

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

CN Energy

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NextNRG

Meiwu Tech

Generation Income Properties

MetaVia

OceanPal

Ordinary dividend (cash)

Ex Date: 2026.06.15 (EST), Cash dividend 0.11 USD

BMEZ

Last week's inflation reports present a 10.3% dividend opportunity through two closed-end funds (CEFs). The strategy involves securing this yield now before anticipated interest rate declines. The DoubleLine Income Solutions Fund (DSL) offers a 12% payout, while the BlackRock Health Sciences Term Trust (BMEZ) provides a 9.3% yield. Both funds are currently undervalued, making this an opportune time for investment as AI impacts inflation and wage growth.

nasdaq

Doubleline Income Solutions

Goldman Sachs

Merck

Moderna

Gilead Sciences

GS Hldg R

The Interest Rate "Surprise" Everyone's Ignoring (and the 10.3% Dividend That Profits From it)

The global stigmasterol-rich plant sterols market is projected to reach USD 1,281.42 million by 2036, driven by rising cardiovascular health awareness and demand for functional foods. The market is transitioning towards standardized formulations and regulatory support, with significant growth in applications across food, nutraceuticals, and pharmaceuticals. Key growth regions include India, Germany, and China, with a forecast CAGR of 3.8% from 2026 to 2036. The market is bolstered by increasing consumer preference for plant-based wellness solutions and regulatory approvals for health claims.

MorningStar

Stigmasterol-Rich Plant Sterols Market to Reach USD 1,281.42 Million by 2036 as Cardiovascular Health Awareness and Functional Food Demand Expand Globally

The Global Luminex Multiplex Assays Market is projected to grow from USD 1.82 billion in 2025 to USD 3.89 billion by 2033, at a CAGR of 10.0%. This growth is driven by the rising demand for high-throughput biomarker profiling and standardized testing workflows. Key factors include the efficiency of multiplex systems, regulatory support for standardized panels, and the expansion of outsourced research models. However, challenges such as validation complexity and elevated costs may impact adoption rates.

fidelity

Luminex Multiplex Assays Market Projected to Reach USD 3.89 Billion by 2033, Driven by Rising Demand for High-Throughput Biomarker Profiling and Standardized Multiplex Testing Workflows: Verified Market Research

BlackRock announced updates to the managed dividend plans for BMEZ, BSTZ, and BTX

Zhitong

BlackRock Health Sciences Term Trust (BMEZ) announced the final results of its tender offer for up to 40% of its outstanding common shares, which expired on April 17, 2025. The offer was undersubscribed, and the Fund will purchase all properly tendered shares. Payment for accepted shares is expected by April 25, 2025. The purchase price is set at $14.2086, equating to 99.5% of the Fund’s net asset value per share as of April 21, 2025.

StockTitan

Essential Properties Realty

BlackRock

BlackRock Health Sciences Term Trust (BMEZ) Announces Final Results of Tender Offer | BMEZ Stock News

BlackRock Health Sciences Term Trust (BMEZ) announced the expiration and preliminary results of its tender offer for up to 40% of its outstanding common shares. The tender offer, which began on March 21, 2025, was undersubscribed, with 38,753,713 shares tendered. Shareholders who properly tendered their shares will receive 99.5% of the Fund's net asset value as of April 21, 2025. Final results are expected to be announced around the same date.

BlackRock Health Sciences Term Trust (BMEZ) Announces Expiration and Preliminary Results of Tender Offer | BMEZ Stock News

BlackRock Health Sciences Term Trust(BMEZ.US)

The Interest Rate "Surprise" Everyone's Ignoring (and the 10.3% Dividend That Profits From it)

Stigmasterol-Rich Plant Sterols Market to Reach USD 1,281.42 Million by 2036 as Cardiovascular Health Awareness and Functional Food Demand Expand Globally

Luminex Multiplex Assays Market Projected to Reach USD 3.89 Billion by 2033, Driven by Rising Demand for High-Throughput Biomarker Profiling and Standardized Multiplex Testing Workflows: Verified Market Research

BlackRock announced updates to the managed dividend plans for BMEZ, BSTZ, and BTX

BlackRock Health Sciences Term Trust (BMEZ) Announces Final Results of Tender Offer | BMEZ Stock News